Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 741 entries
Sorted by: Best Match Show Resources per page
Declaration.

British journal of pharmacology

[No authors listed]
PMID: 26814172
Br J Pharmacol. 2016 Feb;173(3):628. doi: 10.1111/bph.13405.

No abstract available.

Cite
Declaration. Br J Pharmacol. 2016;173(3):628doi: 10.1111/bph.13405.
(2016). Declaration. British journal of pharmacology, 173(3), 628. https://doi.org/10.1111/bph.13405
"Declaration." British journal of pharmacology vol. 173,3 (2016): 628. doi: https://doi.org/10.1111/bph.13405
Declaration. Br J Pharmacol. 2016 Feb;173(3):628. doi: 10.1111/bph.13405. PMID: 26814172; PMCID: PMC4728420.
Copy Download .nbib Format: NLM
Genetic deficit of K.

British journal of pharmacology

Wandall-Frostholm C, Dalsgaard T, Bajoriūnas V, Oliván-Viguera A, Sadda V, Beck L, Mogensen S, Stankevicius E, Simonsen U, Köhler R.
PMID: 26102209
Br J Pharmacol. 2015 Sep;172(18):4493-4505. doi: 10.1111/bph.13234. Epub 2015 Jul 24.

BACKGROUND AND PURPOSE: The intermediate conductance calcium/calmodulin-regulated KEXPERIMENTAL APPROACH: An opener of TRPV4 channels, GSK1016790A, was infused in wild-type (wt) and KKEY RESULTS: In wt mice, GSK1016790A decreased right ventricular and systemic pressure leading to a fatal circulatory collapse...

Cite
Wandall-Frostholm C, Dalsgaard T, Bajoriūnas V, et al. Genetic deficit of K. Br J Pharmacol. 2015;172(18):4493-4505doi: 10.1111/bph.13234.
Wandall-Frostholm, C., Dalsgaard, T., Bajoriūnas, V., Oliván-Viguera, A., Sadda, V., Beck, L., Mogensen, S., Stankevicius, E., Simonsen, U., & Köhler, R. (2015). Genetic deficit of K. British journal of pharmacology, 172(18), 4493-4505. https://doi.org/10.1111/bph.13234
Wandall-Frostholm, Christine, et al. "Genetic deficit of K." British journal of pharmacology vol. 172,18 (2015): 4493-4505. doi: https://doi.org/10.1111/bph.13234
Wandall-Frostholm C, Dalsgaard T, Bajoriūnas V, Oliván-Viguera A, Sadda V, Beck L, Mogensen S, Stankevicius E, Simonsen U, Köhler R. Genetic deficit of K. Br J Pharmacol. 2015 Sep;172(18):4493-4505. doi: 10.1111/bph.13234. Epub 2015 Jul 24. PMID: 26102209; PMCID: PMC4562510.
Copy Download .nbib Format: NLM
Drug repurposing from the perspective of pharmaceutical companies.

British journal of pharmacology

Cha Y, Erez T, Reynolds IJ, Kumar D, Ross J, Koytiger G, Kusko R, Zeskind B, Risso S, Kagan E, Papapetropoulos S, Grossman I, Laifenfeld D.
PMID: 28369768
Br J Pharmacol. 2018 Jan;175(2):168-180. doi: 10.1111/bph.13798. Epub 2017 May 18.

Drug repurposing holds the potential to bring medications with known safety profiles to new patient populations. Numerous examples exist for the identification of new indications for existing molecules, most stemming from serendipitous findings or focused recent efforts specifically limited...

Cite
Cha Y, Erez T, Reynolds IJ, et al. Drug repurposing from the perspective of pharmaceutical companies. Br J Pharmacol. 2017;175(2):168-180doi: 10.1111/bph.13798.
Cha, Y., Erez, T., Reynolds, I. J., Kumar, D., Ross, J., Koytiger, G., Kusko, R., Zeskind, B., Risso, S., Kagan, E., Papapetropoulos, S., Grossman, I., & Laifenfeld, D. (2018). Drug repurposing from the perspective of pharmaceutical companies. British journal of pharmacology, 175(2), 168-180. https://doi.org/10.1111/bph.13798
Cha, Y, et al. "Drug repurposing from the perspective of pharmaceutical companies." British journal of pharmacology vol. 175,2 (2018): 168-180. doi: https://doi.org/10.1111/bph.13798
Cha Y, Erez T, Reynolds IJ, Kumar D, Ross J, Koytiger G, Kusko R, Zeskind B, Risso S, Kagan E, Papapetropoulos S, Grossman I, Laifenfeld D. Drug repurposing from the perspective of pharmaceutical companies. Br J Pharmacol. 2018 Jan;175(2):168-180. doi: 10.1111/bph.13798. Epub 2017 May 18. PMID: 28369768; PMCID: PMC5758385.
Copy Download .nbib Format: NLM
Erratum.

British journal of pharmacology

[No authors listed]
PMID: 27553519
Br J Pharmacol. 2016 Sep;173(18):2808. doi: 10.1111/bph.13572.

No abstract available.

Cite
Erratum. Br J Pharmacol. 2016;173(18):2808doi: 10.1111/bph.13572.
(2016). Erratum. British journal of pharmacology, 173(18), 2808. https://doi.org/10.1111/bph.13572
"Erratum." British journal of pharmacology vol. 173,18 (2016): 2808. doi: https://doi.org/10.1111/bph.13572
Erratum. Br J Pharmacol. 2016 Sep;173(18):2808. doi: 10.1111/bph.13572. PMID: 27553519; PMCID: PMC4995291.
Copy Download .nbib Format: NLM
A simple recording impulse counter.

British journal of pharmacology and chemotherapy

THORP RH.
PMID: 18102595
Br J Pharmacol Chemother. 1948 Dec;3(4):271. doi: 10.1111/j.1476-5381.1948.tb00386.x.

No abstract available.

Cite
THORP RH. A simple recording impulse counter. Br J Pharmacol Chemother. 1948;3(4):271doi: 10.1111/j.1476-5381.1948.tb00386.x.
THORP, R. H. (1948). A simple recording impulse counter. British journal of pharmacology and chemotherapy, 3(4), 271. https://doi.org/10.1111/j.1476-5381.1948.tb00386.x
THORP, R H. "A simple recording impulse counter." British journal of pharmacology and chemotherapy vol. 3,4 (1948): 271. doi: https://doi.org/10.1111/j.1476-5381.1948.tb00386.x
THORP RH. A simple recording impulse counter. Br J Pharmacol Chemother. 1948 Dec;3(4):271. doi: 10.1111/j.1476-5381.1948.tb00386.x. PMID: 18102595; PMCID: PMC1509858.
Copy Download .nbib Format: NLM
Chemotherapeutic action of dyes in typhus infection of mice.

British journal of pharmacology and chemotherapy

Andrewes CH, King H, Walker J.
PMID: 19108073
Br J Pharmacol Chemother. 1946 Mar;1(1):15-20.

No abstract available.

Cite
Andrewes CH, King H, Walker J. Chemotherapeutic action of dyes in typhus infection of mice. Br J Pharmacol Chemother. 1946;1(1):15-20
Andrewes, C. H., King, H., & Walker, J. (1946). Chemotherapeutic action of dyes in typhus infection of mice. British journal of pharmacology and chemotherapy, 1(1), 15-20.
Andrewes, C H, et al. "Chemotherapeutic action of dyes in typhus infection of mice." British journal of pharmacology and chemotherapy vol. 1,1 (1946): 15-20.
Andrewes CH, King H, Walker J. Chemotherapeutic action of dyes in typhus infection of mice. Br J Pharmacol Chemother. 1946 Mar;1(1):15-20. PMID: 19108073; PMCID: PMC1509716.
Copy Download .nbib Format: NLM
Analgesic action of pethidine derivatives and related compounds.

British journal of pharmacology and chemotherapy

Macdonald AD, Woolfe G, Bergel F, Morrison AL, Rinderknecht H.
PMID: 19108075
Br J Pharmacol Chemother. 1946 Mar;1(1):4-14.

No abstract available.

Cite
Macdonald AD, Woolfe G, Bergel F, et al. Analgesic action of pethidine derivatives and related compounds. Br J Pharmacol Chemother. 1946;1(1):4-14
Macdonald, A. D., Woolfe, G., Bergel, F., Morrison, A. L., & Rinderknecht, H. (1946). Analgesic action of pethidine derivatives and related compounds. British journal of pharmacology and chemotherapy, 1(1), 4-14.
Macdonald, A D, et al. "Analgesic action of pethidine derivatives and related compounds." British journal of pharmacology and chemotherapy vol. 1,1 (1946): 4-14.
Macdonald AD, Woolfe G, Bergel F, Morrison AL, Rinderknecht H. Analgesic action of pethidine derivatives and related compounds. Br J Pharmacol Chemother. 1946 Mar;1(1):4-14. PMID: 19108075; PMCID: PMC1509718.
Copy Download .nbib Format: NLM
The effects of ion changes on the contraction of the rat uterus stimulated by oxytocin.

British journal of pharmacology and chemotherapy

Bentley PJ, McEwen E.
PMID: 19108144
Br J Pharmacol Chemother. 1961 Feb;16(1):45-9. doi: 10.1111/j.1476-5381.1961.tb00296.x.

The contraction of the rat uterus to oxytocin was measured when it was bathed in various solutions. Substitution of nitrate or bromide for two-thirds of the chloride present increased the size of contractions, while a similar substitution of sulphate...

Cite
Bentley PJ, McEwen E. The effects of ion changes on the contraction of the rat uterus stimulated by oxytocin. Br J Pharmacol Chemother. 1961;16(1):45-9doi: 10.1111/j.1476-5381.1961.tb00296.x.
Bentley, P. J., & McEwen, E. (1961). The effects of ion changes on the contraction of the rat uterus stimulated by oxytocin. British journal of pharmacology and chemotherapy, 16(1), 45-9. https://doi.org/10.1111/j.1476-5381.1961.tb00296.x
Bentley, P J, and McEwen, E. "The effects of ion changes on the contraction of the rat uterus stimulated by oxytocin." British journal of pharmacology and chemotherapy vol. 16,1 (1961): 45-9. doi: https://doi.org/10.1111/j.1476-5381.1961.tb00296.x
Bentley PJ, McEwen E. The effects of ion changes on the contraction of the rat uterus stimulated by oxytocin. Br J Pharmacol Chemother. 1961 Feb;16(1):45-9. doi: 10.1111/j.1476-5381.1961.tb00296.x. PMID: 19108144; PMCID: PMC1481998.
Copy Download .nbib Format: NLM
Metabolism of [c]-histamine in heart-lung-liver preparations of cats.

British journal of pharmacology and chemotherapy

Lilja B, Lindell SE.
PMID: 19108148
Br J Pharmacol Chemother. 1961 Apr;16(2):203-8. doi: 10.1111/j.1476-5381.1961.tb00314.x.

The metabolism of injected [(14)C]-histamine was studied in heart-lung-liver preparations and heart-lung preparations from cats. When the liver was included in the circulation the injected histamine was rapidly eliminated from the blood, some of its metabolites appearing in the...

Cite
Lilja B, Lindell SE. Metabolism of [c]-histamine in heart-lung-liver preparations of cats. Br J Pharmacol Chemother. 1961;16(2):203-8doi: 10.1111/j.1476-5381.1961.tb00314.x.
Lilja, B., & Lindell, S. E. (1961). Metabolism of [c]-histamine in heart-lung-liver preparations of cats. British journal of pharmacology and chemotherapy, 16(2), 203-8. https://doi.org/10.1111/j.1476-5381.1961.tb00314.x
Lilja, B, and Lindell, S E. "Metabolism of [c]-histamine in heart-lung-liver preparations of cats." British journal of pharmacology and chemotherapy vol. 16,2 (1961): 203-8. doi: https://doi.org/10.1111/j.1476-5381.1961.tb00314.x
Lilja B, Lindell SE. Metabolism of [c]-histamine in heart-lung-liver preparations of cats. Br J Pharmacol Chemother. 1961 Apr;16(2):203-8. doi: 10.1111/j.1476-5381.1961.tb00314.x. PMID: 19108148; PMCID: PMC1481960.
Copy Download .nbib Format: NLM
Sensitivity of the hyperthyroid and hypothyroid mouse to histamine and 5-hydroxytryptamine.

British journal of pharmacology and chemotherapy

Spencer PS, West GB.
PMID: 19108156
Br J Pharmacol Chemother. 1961 Aug;17(1):137-43. doi: 10.1111/j.1476-5381.1961.tb01114.x.

Injections of thyroxine sodium increased the sensitivity of mice to histamine, the maximal effect occurring after 6 days. The sensitivity to 5-hydroxytryptamine was increased to a lesser extent. Hydrocortisone antagonized this effect of thyroxine, whereas anti-thyroid drugs alone decreased...

Cite
Spencer PS, West GB. Sensitivity of the hyperthyroid and hypothyroid mouse to histamine and 5-hydroxytryptamine. Br J Pharmacol Chemother. 1961;17(1):137-43doi: 10.1111/j.1476-5381.1961.tb01114.x.
Spencer, P. S., & West, G. B. (1961). Sensitivity of the hyperthyroid and hypothyroid mouse to histamine and 5-hydroxytryptamine. British journal of pharmacology and chemotherapy, 17(1), 137-43. https://doi.org/10.1111/j.1476-5381.1961.tb01114.x
Spencer, P S, and West, G B. "Sensitivity of the hyperthyroid and hypothyroid mouse to histamine and 5-hydroxytryptamine." British journal of pharmacology and chemotherapy vol. 17,1 (1961): 137-43. doi: https://doi.org/10.1111/j.1476-5381.1961.tb01114.x
Spencer PS, West GB. Sensitivity of the hyperthyroid and hypothyroid mouse to histamine and 5-hydroxytryptamine. Br J Pharmacol Chemother. 1961 Aug;17(1):137-43. doi: 10.1111/j.1476-5381.1961.tb01114.x. PMID: 19108156; PMCID: PMC1482074.
Copy Download .nbib Format: NLM
Histamine release by bee venom phospholipase a and mellitin in the rat.

British journal of pharmacology and chemotherapy

Rothschild AM.
PMID: 19108211
Br J Pharmacol Chemother. 1965 Aug;25(1):59-66. doi: 10.1111/j.1476-5381.1965.tb01756.x.

No abstract available.

Cite
Rothschild AM. Histamine release by bee venom phospholipase a and mellitin in the rat. Br J Pharmacol Chemother. 1965;25(1):59-66doi: 10.1111/j.1476-5381.1965.tb01756.x.
Rothschild, A. M. (1965). Histamine release by bee venom phospholipase a and mellitin in the rat. British journal of pharmacology and chemotherapy, 25(1), 59-66. https://doi.org/10.1111/j.1476-5381.1965.tb01756.x
Rothschild, A M. "Histamine release by bee venom phospholipase a and mellitin in the rat." British journal of pharmacology and chemotherapy vol. 25,1 (1965): 59-66. doi: https://doi.org/10.1111/j.1476-5381.1965.tb01756.x
Rothschild AM. Histamine release by bee venom phospholipase a and mellitin in the rat. Br J Pharmacol Chemother. 1965 Aug;25(1):59-66. doi: 10.1111/j.1476-5381.1965.tb01756.x. PMID: 19108211; PMCID: PMC1510690.
Copy Download .nbib Format: NLM
The difference in behaviour of basophil leucocytes and mast cells towards compound 48/80.

British journal of pharmacology and chemotherapy

Haye KR, Schneider R.
PMID: 19108222
Br J Pharmacol Chemother. 1966 Dec;28(3):282-8. doi: 10.1111/j.1476-5381.1966.tb01895.x.

No abstract available.

Cite
Haye KR, Schneider R. The difference in behaviour of basophil leucocytes and mast cells towards compound 48/80. Br J Pharmacol Chemother. 1966;28(3):282-8doi: 10.1111/j.1476-5381.1966.tb01895.x.
Haye, K. R., & Schneider, R. (1966). The difference in behaviour of basophil leucocytes and mast cells towards compound 48/80. British journal of pharmacology and chemotherapy, 28(3), 282-8. https://doi.org/10.1111/j.1476-5381.1966.tb01895.x
Haye, K R, and Schneider, R. "The difference in behaviour of basophil leucocytes and mast cells towards compound 48/80." British journal of pharmacology and chemotherapy vol. 28,3 (1966): 282-8. doi: https://doi.org/10.1111/j.1476-5381.1966.tb01895.x
Haye KR, Schneider R. The difference in behaviour of basophil leucocytes and mast cells towards compound 48/80. Br J Pharmacol Chemother. 1966 Dec;28(3):282-8. doi: 10.1111/j.1476-5381.1966.tb01895.x. PMID: 19108222; PMCID: PMC1510878.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 741 entries